Invacare

Global Mobility Scooters Market Report 2022: Outlook, Opportunities, Demand Analysis, & Forecasts, 2019-2028 - ResearchAndMarkets.com

Retrieved on: 
Thursday, May 5, 2022
General Automotive, Other Automotive, Automotive, Accident, Players, Knee, Electrical mobility, CAGR, Growth, Awareness, Wheelchair, Invacare, Acquisition, Car rental, Personal, Mobility, ORAC, Wheel

Global Mobility Scooters Market is anticipated to rise at a value CAGR of 7.65% over 2019-2028.

Key Points: 
  • Global Mobility Scooters Market is anticipated to rise at a value CAGR of 7.65% over 2019-2028.
  • The rise in the initiatives by the government authorities to provide mobility scooters at subsidized rates and technological advancements in Mobility scooters have further fostered the market revenue.
  • The rise in awareness among individual for the use of mobility scooters have escalated the demand of the market.
  • The Players of the Global Mobility Scooters Market are fragmented.

Invacare Corporation to Host Conference Call and Webcast to Discuss First Quarter 2022 Financial Results

Retrieved on: 
Friday, April 22, 2022
Medical Devices, Health, ALS, Rest, Rancho Los Amigos National Rehabilitation Center, Cerebral palsy, Government, Telephone, COPD, Invacare, Muscular dystrophy, Multiple sclerosis, Stroke, Chronic obstructive pulmonary disease, Conference, Corporation, IVC, Health, Webcast, NYSE, Spina bifida

Invacare Corporation (NYSE: IVC) (Invacare or the company) announces that it will release its financial results for the first quarter ended March 31, 2022, after the market closes on Monday, May 9, 2022.

Key Points: 
  • Invacare Corporation (NYSE: IVC) (Invacare or the company) announces that it will release its financial results for the first quarter ended March 31, 2022, after the market closes on Monday, May 9, 2022.
  • The company will provide a live conference call and webcast to discuss these financial results on Tuesday, May 10, 2022, at 8:30 AM ET.
  • A recording of the conference call can be accessed by dialing 929-458-6194 and entering the Conference ID Code 041270, through May 24, 2022.
  • Invacare Corporation is a leading manufacturer and distributor in its markets for medical equipment used in non-acute care settings.

Dentsply Sirona Provides Corporate Update

Retrieved on: 
Tuesday, April 19, 2022
Board, Columbia Business School, Dentistry, CEO, GAAP, XRAY, Information technology, Marketing, Becton, Minor, Becton, Dickinson and Company headquarters, MBA, Mechanical, Audit committee, Annual report, C. R. Bard, Acceleration, East Asian studies, GLOBE, CFO, Patient, Eli Lilly and Company, Boston Scientific, Mission statement, Sirona, Kettering University, Â, Health, Company, Nasdaq, United Kingdom, Therapy, Hospira, Solution, Mallinckrodt, Coronavirus, Invacare, Industry, Eli Lilly, Acquisition, Senior, Interim, Guidant, Management, Online gambling, Economics, Science, Hillrom, Indiana University, Finance

CHARLOTTE, N.C., April 19, 2022 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or “the Company”) (Nasdaq: XRAY) today announced the appointment of John Groetelaars, who serves on Dentsply Sirona’s Board of Directors, as Interim Chief Executive Officer. He succeeds Don Casey, who has been terminated as CEO and will cease to serve as a member of the Company’s Board, effective immediately. The Board has initiated a search to identify the Company’s next CEO and has retained a leading executive search firm to support the process.

Key Points: 
  • CHARLOTTE, N.C., April 19, 2022 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (Dentsply Sirona or the Company) (Nasdaq: XRAY)today announced the appointment of John Groetelaars, who serves on Dentsply Sironas Board of Directors, as Interim Chief Executive Officer.
  • Dentsply Sirona is situated in attractive, growing dental categories and has a strong foundation in place, built on its portfolio of leading products and differentiated position across key markets.
  • Dentsply Sirona also today announced the appointment of Barbara Bodem as Interim Chief Financial Officer, effective upon Jorge Gomezs previously announced departure on May 6, 2022.
  • Dentsply Sirona today also provided an update on its anticipated financial results for the first quarter ending March 31, 2022.

Invacare Corporation Appoints Aron I. Schwartz to Board of Directors

Retrieved on: 
Monday, March 21, 2022
Professional Services, Medical Devices, Health, Finance, Managed Care, General Health, D.C, Multiple sclerosis, Partner, ACON Investments, Growth, Health, Board, NYSE, ALS, Cerebral palsy, Corporation, IVC, Board of directors, Rancho Los Amigos National Rehabilitation Center, Government, Avenue Capital Group, Stroke, Muscular dystrophy, Investment, Fenway Partners, COPD, Housing, Communities and Local Government Committee, Spina bifida, Chronic obstructive pulmonary disease, Rest, Security (finance), Management, Invacare

Invacare Corporation (NYSE: IVC) today announced the appointment of Aron I. Schwartz, age 51, to its Board of Directors, effective March 21, 2022.

Key Points: 
  • Invacare Corporation (NYSE: IVC) today announced the appointment of Aron I. Schwartz, age 51, to its Board of Directors, effective March 21, 2022.
  • Mr. Schwartz was unanimously appointed by the current members of the Board and will serve on the companys Audit Committee and its Nominating and Governance Committee.
  • His appointment brings the number of Invacare directors to a total of nine, eight of whom are independent.
  • I am excited to join Invacares Board of Directors, and work with the board and management team to help drive sustainable growth and solidify the company's leadership position.

Invacare Corporation to Participate at March Conferences

Retrieved on: 
Wednesday, March 2, 2022
Medical Devices, Health, Rancho Los Amigos National Rehabilitation Center, Cerebral palsy, Spina bifida, Corporation, Rest, Invacare, Government, Chronic obstructive pulmonary disease, NYSE, Health, Medtech, Company, Conference, COPD, Stroke, Multiple sclerosis, Muscular dystrophy, Treasury, ALS, IVC, Pharmaceutical industry

Invacare Corporation (NYSE: IVC) a leading manufacturer and distributor of medical equipment used in non-acute care settings, announces its conference schedule for March 2022:

Key Points: 
  • Invacare Corporation (NYSE: IVC) a leading manufacturer and distributor of medical equipment used in non-acute care settings, announces its conference schedule for March 2022:
    Tuesday, March 15, the Company will participate in the 32nd Annual Oppenheimer Healthcare Conference.
  • Tuesday, March 22, the Company will participate in the KeyBanc Life Sciences & MedTech Investor Forum.
  • Invacare Corporation is a leading manufacturer and distributor in its markets for medical equipment used in non-acute care settings.
  • At its core, the company designs, manufactures and distributes medical devices that help people to move, breathe, rest and perform essential hygiene.

World Medical Mattress Market Research Report 2022 - ResearchAndMarkets.com

Retrieved on: 
Wednesday, March 2, 2022
Retail, Health, Hospitals, Home Goods, Specialty, Managed Care, Risk, Ageing, Chronic Respiratory Disease, Patient, Investment, Degenerative disease, Longevity, Hospital, Rest, Industry, Medicine, Population, Growth, Urbanization, US, Cancer, COVID-19, Medline Industries, World Economic Forum, Invacare, CAGR, Diabetes, Spine, Health, Sleep, Incidence, Back pain, Animal, Pharmaceutical industry, Agriculture

Based on end-user, the global medical mattress market is bifurcated into residential and commercial.

Key Points: 
  • Based on end-user, the global medical mattress market is bifurcated into residential and commercial.
  • Also, the growing demand for the medical mattress in numerous applications along with significant investments by prominent manufacturers is predicted to bolster the medical mattress market growth globally in the coming years.
  • Blue Chip Medical Products, Inc.; Blake Medical; Desco Medical; Icare Medical Group; Invacare Corporation; LINET; Medline Industries, Inc.; Narang Medical Limited.
  • ; Paramount Bed Holdings Co., Ltd.; and TEKVOR-CARE GMBH are among the well-established players operating in the global medical mattress market.

Global Respiratory Care Devices Industry to Cross $36.96B by 2027 - Trends, Opportunities, Impact of COVID-19, Company Analysis, and More - ResearchAndMarkets.com

Retrieved on: 
Thursday, February 24, 2022
Medical Devices, Health, CDC, Physician, Population, Philips, Masimo, Death, Global, Urbanization, Hospital, Mouth, WHO, Chronic obstructive pulmonary disease, Prevalence, PAP, Center, Asthma, COVID-19, Sleep apnea, Industry, World, Smoking, Centers for Disease Control and Prevention timeline, Johnson & Johnson, Degenerative disease, Tobacco smoking, Adoption, Nose, Medtronic, ResMed, COPD, World Health Organization, Ageing, Patient, Air pollution, Medical tourism, Humidifier, BD (company), Research, Incidence, Obstructive sleep apnea, Nebulizer, Animal, Pharmaceutical industry, Invacare, Growth

The Global Respiratory Care Devices Market is expected to reach US$ 36.96 billion by 2027.

Key Points: 
  • The Global Respiratory Care Devices Market is expected to reach US$ 36.96 billion by 2027.
  • It expresses the emphasis on respiratory care in the background of a pandemic; the respiratory care devices market has shown healthy growth.
  • Based on product type, the global respiratory care devices industry is segmented into monitoring devices, therapeutic devices, diagnostic devices, and consumables & accessories.
  • The therapeutic devices segment has accounted for a significant share of the global respiratory care devices industry.

Invacare Corporation to Host Conference Call and Webcast to Discuss Fourth Quarter and Full Year 2021 Financial Results

Retrieved on: 
Wednesday, February 9, 2022
Medical Devices, Health, IVC, Invacare, Government, Health, Telephone, ALS, Conference, Rancho Los Amigos National Rehabilitation Center, COPD, Multiple sclerosis, Cerebral palsy, Spina bifida, Corporation, Chronic obstructive pulmonary disease, Rest, NYSE, Stroke, Webcast, Muscular dystrophy

Invacare Corporation (NYSE: IVC) (Invacare or the company) announces that it will release its financial results for the fourth quarter and year ended December 31, 2021, after the market closes on Tuesday, March 8, 2022.

Key Points: 
  • Invacare Corporation (NYSE: IVC) (Invacare or the company) announces that it will release its financial results for the fourth quarter and year ended December 31, 2021, after the market closes on Tuesday, March 8, 2022.
  • The company will provide a live conference call and webcast to discuss these financial results on Wednesday, March 9, 2022 at 8:30 AM ET.
  • A recording of the conference call can be accessed by dialing 929-458-6194 and entering the Conference ID Code 133182, through March 23, 2022.
  • Invacare Corporation is a leading manufacturer and distributor in its markets for medical equipment used in non-acute care settings.

Invacare Corporation Introduces Its Next Generation e-fix eco Power Assist Device to Transform the Manual Wheelchair

Retrieved on: 
Monday, February 7, 2022
General Health, Health, Medical Devices, IVC, Invacare, Industry, Government, Culture, Health, ALS, Rancho Los Amigos National Rehabilitation Center, COPD, Multiple sclerosis, Cerebral palsy, Birth, Spina bifida, Chronic obstructive pulmonary disease, Corporation, Rest, NYSE, Stroke, Muscular dystrophy

Invacare Corporation (NYSE: IVC) announced the introduction of its next generation of power assist devices the e-fix eco.

Key Points: 
  • Invacare Corporation (NYSE: IVC) announced the introduction of its next generation of power assist devices the e-fix eco.
  • The Alber e-fix eco Power Assist transforms a manual wheelchair into a portable power chair via a joystick, battery and in-wheel motors.
  • Equipped with a new modern design for the wheel hub, color display, battery, and battery bag, the e-fix eco represents a significant upgrade from the previous generation.
  • In addition, the eco features a clutch, multiple joystick options and energy recovering braking technology, which transfers power back into the battery.

Invacare Corporation Introduces the Invacare® AVIVA® STORM RX™ Narrow Base Power Wheelchair

Retrieved on: 
Monday, January 31, 2022
Medical Supplies, Medical Devices, Health, Other Health, Managed Care, General Health, Government, AVIVA, Spina bifida, ALS, Health, Cerebral palsy, Technology, Environment, Linx, Corporation, Stroke, Noise, ASL, IVC, Rancho Los Amigos National Rehabilitation Center, COPD, Birth, Chronic obstructive pulmonary disease, Rest, VP, NYSE, Muscular dystrophy, Multiple sclerosis, Traction, Taxicab, Cassette tape, Invacare

Invacare Corporation (NYSE: IVC) today announced the introduction of a new, narrower version of the Invacare AVIVA STORM RX rear wheel drive power wheelchair.

Key Points: 
  • Invacare Corporation (NYSE: IVC) today announced the introduction of a new, narrower version of the Invacare AVIVA STORM RX rear wheel drive power wheelchair.
  • The narrow base model offers several new features compared to the standard version of the AVIVA STORM RX, a next generation chair launched in August 2021, including:
    Im excited about the many benefits the narrow base adds to our already impressive AVIVA STORM RX lineup, the only next generation rear wheel drive power wheelchairs that truly have 4 wheels on the ground.
  • With a short wheelbase and narrow width, the AVIVA STORM RX gives a compact base footprint for excellent maneuverability.
  • To find out more about the Invacare AVIVA STORM RX Narrow Base Power Wheelchair, visit https://rehab.invacare.com/ .